It is of note, that many of the top ranked p16 positive tumor entities such as small cell neuroendocrine carcinoma of the bladder, Merkel cell carcinoma, small cell carcinoma of the lung and small cell neuroendocrine carcinoma of the prostate exhibit neuroendocrine differentiation. This evidence concerns the gene CDKN2A and small cell lung carcinoma.